Protein arginine methylation: from enigmatic functions to therapeutic targeting

Q Wu, M Schapira, CH Arrowsmith… - Nature reviews Drug …, 2021 - nature.com
Protein arginine methyltransferases (PRMTs) are emerging as attractive therapeutic targets.
PRMTs regulate transcription, splicing, RNA biology, the DNA damage response and cell …

The PPARα and PPARγ epigenetic landscape in cancer and immune and metabolic disorders

J Porcuna, J Mínguez-Martínez, M Ricote - International journal of …, 2021 - mdpi.com
Peroxisome proliferator-activated receptors (PPARs) are ligand-modulated nuclear
receptors that play pivotal roles in nutrient sensing, metabolism, and lipid-related processes …

PRMT5 activates AKT via methylation to promote tumor metastasis

L Huang, XO Zhang, EJ Rozen, X Sun, B Sallis… - Nature …, 2022 - nature.com
Abstract Protein arginine methyltransferase 5 (PRMT5) is the primary methyltransferase
generating symmetric-dimethyl-arginine marks on histone and non-histone proteins. PRMT5 …

[HTML][HTML] PRMT5 in gene regulation and hematologic malignancies

F Zhu, L Rui - Genes & Diseases, 2019 - Elsevier
Arginine methylation is a common posttranslational modification that governs important
cellular processes and impacts development, cell growth, proliferation, and differentiation …

PRMT5 activates KLF5 by methylation to facilitate lung cancer

H Zhou, J Chang, J Zhang, H Zheng… - Journal of cellular …, 2024 - Wiley Online Library
The highly expressed oncogenic factor Krüppel‐like factor 5 (KLF5) promotes various
cancerous processes, such as cell growth, survival, anti‐apoptosis, migration and …

PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells

F Zhu, H Guo, PD Bates, S Zhang, H Zhang, KJ Nomie… - Leukemia, 2019 - nature.com
PRMT5, which regulates gene expression by symmetric dimethylation of histones and non-
histone target proteins, is overexpressed and plays a pathogenic role in many cancers. In …

Histone modifications in NAFLD: Mechanisms and potential therapy

Y Shi, W Qi - International Journal of Molecular Sciences, 2023 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that encompasses a
spectrum of liver disorders, beginning with the simple steatosis, progressing to nonalcoholic …

Post-translational modifications of histone and non-histone proteins in epigenetic regulation and translational applications in alcohol-associated liver disease …

W Rungratanawanich, JW Ballway, X Wang… - Pharmacology & …, 2023 - Elsevier
Epigenetic regulation is a process that takes place through adaptive cellular pathways
influenced by environmental factors and metabolic changes to modulate gene activity with …

[HTML][HTML] PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades

Y Yan, P Zhao, Z Wang, Z Liu, Z Wang, J Zhang… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Emerging evidence shows that type II protein arginine methyltransferase 5 (PRMT5) serves
as an oncoprotein and plays a critical role in many types of human cancer. However, the …

Hepatocellular BChE as a therapeutic target to ameliorate hypercholesterolemia through PRMT5 selective degradation to restore LDL receptor transcription

D Wang, KS Tan, W Zeng, S Li, Y Wang, F Xu, W Tan - Life Sciences, 2022 - Elsevier
Aims Individuals with nonalcoholic hepatosteatosis (NAFLD) have a worse atherogenic
lipoprotein profile and are susceptible to cardiovascular diseases. The MEK-ERK signaling …